Life Insurance Corporation of India (LIC) has introduced 2 fresh life savings products and a health rider to bolster its offerings for Indian customers. Launching from 4 July 2025, these new schemes aim to cater to varied investor preferences while extending protection against critical illnesses.
LIC’s Nav Jeevan Shree and its single-premium counterpart, Nav Jeevan Shree – Single Premium, are non-linked, non-participating life savings plans. The former follows a regular premium model, while the latter addresses those who prefer lump-sum investment. Both plans combine savings and insurance, ideal for individuals seeking assured returns and life protection.
LIC has also launched the Critical Illness Health Rider—a non-linked, individual health rider that can be attached to eligible base plans. It provides financial support upon diagnosis of specified critical illnesses, strengthening the base plan’s protection.
These initiatives reflect LIC’s strategy to diversify its product range. By offering both flexible savings instruments and enhanced health protection, LIC is adapting to evolving customer needs in life and health segments. The company’s stock exchange filing confirms that these offerings will be available across LIC distribution channels starting 4 July 2025.
Also Read: LIC’s Stake in NSE Rises Amid IPO Buzz and Legal Resolution Hopes!
As of 4 July 2025, at 01:17 PM, LIC share price is trading at ₹938.60, a 0.78% decline. Over the past month, the stock has declined by about 0.8 %.
With Nav Jeevan Shree’s regular and single‑premium options alongside the Critical Illness Health Rider, LIC enhances its commitment to comprehensive financial planning. The launch marks a timely extension of its life‑and‑health portfolio, enabling consumers to secure savings and protection under one roof.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jul 4, 2025, 1:43 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates